Bukwang Pharm (003000) - Total Liabilities

Latest as of September 2025: ₩132.16 Billion KRW ≈ $89.56 Million USD

Based on the latest financial reports, Bukwang Pharm (003000) has total liabilities worth ₩132.16 Billion KRW (≈ $89.56 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Bukwang Pharm long-term investment allocation to see how much of total assets are deployed in long-term investments.

Bukwang Pharm - Total Liabilities Trend (2007–2024)

This chart illustrates how Bukwang Pharm's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Bukwang Pharm assets under control.

Bukwang Pharm Competitors by Total Liabilities

The table below lists competitors of Bukwang Pharm ranked by their total liabilities.

Company	Country	Total Liabilities
Bank Ochrony Środowiska SA WAR:BOS	Poland	zł24.48 Billion
Super Energy Tbk PT JK:SURE	Indonesia	Rp1.07 Trillion
Kreditbanken A/S CO:KRE	Denmark	Dkr6.44 Billion
Kcc Glass Corp KO:344820	Korea	₩1.07 Trillion
Touchstone International Medical Science Co Ltd SHG:688013	China	CN¥76.41 Million
Empresas Gasco S.A SN:GASCO	Chile	CL$625.17 Billion
Strike Energy Limited F:RJN	Germany	€130.16 Million

Liability Composition Analysis (2007–2024)

This chart breaks down Bukwang Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 003000 net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.60	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.39	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.28	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bukwang Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bukwang Pharm (2007–2024)

The table below shows the annual total liabilities of Bukwang Pharm from 2007 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩129.03 Billion ≈ $87.44 Million	-33.74%
2023-12-31	₩194.75 Billion ≈ $131.98 Million	+50.88%
2022-12-31	₩129.08 Billion ≈ $87.48 Million	+9.99%
2021-12-31	₩117.36 Billion ≈ $79.53 Million	-9.57%
2020-12-31	₩129.78 Billion ≈ $87.95 Million	+109.15%
2019-12-31	₩62.05 Billion ≈ $42.05 Million	-22.61%
2018-12-31	₩80.17 Billion ≈ $54.33 Million	+221.64%
2017-12-31	₩24.93 Billion ≈ $16.89 Million	+8.38%
2016-12-31	₩23.00 Billion ≈ $15.59 Million	-19.32%
2015-12-31	₩28.51 Billion ≈ $19.32 Million	+6.30%
2014-12-31	₩26.82 Billion ≈ $18.17 Million	-1.18%
2013-12-31	₩27.14 Billion ≈ $18.39 Million	-52.00%
2008-12-31	₩56.54 Billion ≈ $38.32 Million	+27.39%
2007-12-31	₩44.39 Billion ≈ $30.08 Million	--

About Bukwang Pharm

KO:003000 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$263.11 Million

₩388.25 Billion KRW

Market Cap Rank

#15535 Global

#528 in Korea

Share Price

₩3935.00

Change (1 day)

+0.13%

52-Week Range

₩3485.00 - ₩9600.00

All Time High

₩36947.85